Wall Street Analysts Believe Silence Therapeutics (SLN) Could Rally 590.66%: Heres is How to Trade The mean of analysts price targets for Silence Therapeutics (SLN) points to a 590.7% upside in the stock. While this…
BMO maintains $67 stock target on Silence Therapeutics stock By Investing.com BMO maintains $67 stock target on Silence Therapeutics stock…